[The significance of cellular surface markers in lymphoproliferative disorders].
D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D008232:Lymphoproliferative Disorders / Q000188:drug therapy / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology*
D000970:Antineoplastic Agents